Wall Street analysts expect Surgery Partners Inc (NASDAQ:SGRY) to announce $478.91 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Surgery Partners’ earnings, with estimates ranging from $469.60 million to $486.00 million. Surgery Partners posted sales of $460.35 million in the same quarter last year, which suggests a positive year-over-year growth rate of 4%. The firm is expected to report its next quarterly earnings report on Thursday, March 7th.
On average, analysts expect that Surgery Partners will report full year sales of $1.78 billion for the current fiscal year, with estimates ranging from $1.76 billion to $1.79 billion. For the next year, analysts expect that the firm will post sales of $1.95 billion, with estimates ranging from $1.90 billion to $2.01 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that cover Surgery Partners.
Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Wednesday, November 7th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The business had revenue of $443.90 million for the quarter, compared to analyst estimates of $440.38 million. Surgery Partners had a negative net margin of 5.55% and a negative return on equity of 1.68%. Surgery Partners’s revenue for the quarter was up 44.9% on a year-over-year basis. During the same period last year, the business posted ($0.02) earnings per share.
Several brokerages recently weighed in on SGRY. BidaskClub raised Surgery Partners from a “sell” rating to a “hold” rating in a research note on Wednesday, November 28th. Zacks Investment Research raised Surgery Partners from a “hold” rating to a “buy” rating and set a $17.00 target price for the company in a research note on Wednesday, October 10th. Royal Bank of Canada raised their target price on Surgery Partners from $18.00 to $20.00 and gave the company an “outperform” rating in a research note on Friday, August 10th. Finally, ValuEngine raised Surgery Partners from a “buy” rating to a “strong-buy” rating in a research note on Thursday, November 1st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $18.29.
A number of hedge funds have recently made changes to their positions in the stock. Wolverine Asset Management LLC boosted its position in shares of Surgery Partners by 493.2% in the 2nd quarter. Wolverine Asset Management LLC now owns 70,163 shares of the company’s stock valued at $1,045,000 after purchasing an additional 58,336 shares during the period. Highland Capital Management LP boosted its position in shares of Surgery Partners by 171.3% in the 2nd quarter. Highland Capital Management LP now owns 323,700 shares of the company’s stock valued at $4,823,000 after purchasing an additional 204,400 shares during the period. Citadel Advisors LLC acquired a new position in shares of Surgery Partners in the 2nd quarter valued at $318,000. Dimensional Fund Advisors LP boosted its position in shares of Surgery Partners by 5.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 571,218 shares of the company’s stock valued at $8,512,000 after purchasing an additional 29,643 shares during the period. Finally, Bank of Montreal Can acquired a new position in shares of Surgery Partners in the 2nd quarter valued at $149,000. 96.96% of the stock is owned by institutional investors and hedge funds.
Shares of SGRY opened at $12.98 on Friday. Surgery Partners has a one year low of $8.53 and a one year high of $19.95. The firm has a market cap of $665.90 million, a PE ratio of -15.45 and a beta of 2.03. The company has a current ratio of 1.57, a quick ratio of 1.42 and a debt-to-equity ratio of 1.72.
Surgery Partners Company Profile
Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Featured Story: What are the Different Types of Leveraged Buyouts?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.